View of A rapid PSA half-life following docetaxel chemotherapy is associated with improved survival in hormone refractory prostate cancer

Return to Article Details A rapid PSA half-life following docetaxel chemotherapy is associated with improved survival in hormone refractory prostate cancer Download Download PDF